ASF1A and hepatocellular carcinoma: Moreover, immunohistochemistry (IHC) of serial sections from HCC patients proved the elevated expression of ASF1A and HJURP in tumor tissues, and HCC patients in the high-risk group had poorer prognosis by IHC staining of HCC tissue microarrays.